Your cart is currently empty.
: Available:
Be the first to ask a question about this.
Ferti M (75IU) Injection contains Menotrophin, a combination of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) derived from human menopausal urine. It is used in the treatment of infertility in women and men. In women, it stimulates the ovaries to develop mature eggs, while in men, it promotes sperm production. Ferti M is usually given under specialist supervision in fertility treatment programs.
Active ingredient: Menotrophin (75 IU of FSH + LH activity)
Excipients: Stabilizers and diluents (may vary by manufacturer)
Gonadotropin (Hormonal fertility drug)
Powder for solution for intramuscular (IM) or subcutaneous (SC) injection
Female infertility due to anovulation (failure to ovulate)
Controlled ovarian stimulation during assisted reproductive techniques (e.g., IVF)
Male infertility due to hypogonadotropic hypogonadism (low LH/FSH leading to reduced sperm production)
⚠️ Dose must be individualized and determined by a fertility specialist.
Women: Usually 75–150 IU daily, beginning within the first 7 days of the menstrual cycle. Adjustments based on ovarian response.
Men: Typically 75 IU 2–3 times per week, often in combination with human chorionic gonadotropin (hCG).
Treatment duration varies depending on response and clinical condition.
Symptoms: Ovarian hyperstimulation (abdominal pain, bloating, nausea, rapid weight gain, breathing difficulty).
Management: Discontinue therapy, provide symptomatic treatment, and monitor closely.
Take the missed dose as soon as remembered if within the same day.
Do not double the dose the next day.
Consult your fertility specialist for guidance.
Administered via intramuscular (IM) or subcutaneous (SC) injection.
Reconstitute powder with the provided solvent before use.
Should only be used under the supervision of a gynecologist, endocrinologist, or fertility expert.
Allergy to menotrophins or other gonadotropins
Ovarian cysts or enlargement not due to PCOS
Unexplained vaginal or uterine bleeding
Tumors of the ovary, breast, uterus, pituitary gland, or hypothalamus
Primary ovarian failure (ovaries no longer respond)
Pregnancy and breastfeeding
Testicular failure in men (primary testicular damage)
Common:
Headache
Injection site pain/redness
Abdominal discomfort or bloating
Serious:
Ovarian Hyperstimulation Syndrome (OHSS): abdominal pain, swelling, nausea, vomiting
Blood clots (rare but serious)
Multiple pregnancies (twins or more)
Allergic reactions (rash, swelling, difficulty breathing)
Should only be administered by a specialist trained in fertility treatment
Risk of OHSS (Ovarian Hyperstimulation Syndrome) — monitor closely
Increased risk of multiple births
Monitor ovarian response with ultrasound and hormone tests
Use cautiously in patients with asthma, blood clotting disorders, or liver/kidney disease
Clomiphene citrate: May increase ovarian response
GnRH analogs (agonists/antagonists): Often used in combination during IVF
Inform your doctor about all fertility drugs and hormonal therapies being used
Store below 25°C, in a cool and dry place
Protect from light and moisture
Do not freeze
Discard any unused solution immediately after reconstitution
Keep out of reach of children
Prescription-only medicine
To be used strictly under fertility specialist supervision
Always follow your fertility doctor’s dosing schedule closely
Report symptoms of OHSS immediately (rapid weight gain, abdominal swelling, shortness of breath)
Maintain regular monitoring with blood tests and ultrasound
May increase the chances of multiple pregnancies
Do not self-administer unless trained by a healthcare provider
Your order of 100$ or more gets free standard delivery.
Orders are processed and delivered Monday-Friday (excluding public holidays)
eMarket members enjoy free returns.

From Rs 5000
Online 24 hours
365 a day
Added to cart successfully. What's next?
Product type: 1
1 x $00.00
